The FY19 Defense Appropriation provides $10 million (M) to the Department of Defense Chronic Pain Management Research Program (CPMRP) to support research of exceptional scientific merit with the potential to make a significant impact on improving the health and quality of life of Service members, Veterans, and all Americans living with chronic pain. As directed by the Office of the Assistant Secretary of Defense for Health Affairs, the Defense Health Agency J9, Research and Development Directorate manages the Defense Health Program (DHP) Research, Development, Test, and Evaluation (RDT&E) appropriation. The managing agent for the anticipated Program Announcements/Funding Opportunities is the Congressionally Directed Medical Research Programs (CDMRP) at the U.S. Army Medical Research and Development Command (USAMRDC).
FY19 CPMRP Program Announcements and General Application Instructions for the following award mechanisms are posted on the Grants.gov website.
Per the FY19 CPMRP Congressional appropriation, chronic pain is defined as a pain that occurs on at least half the days for six months or more, and which can be caused by issues including, but not limited to: combat- and training-related physical or mental stress and trauma, migraines and chronic headaches, traumatic brain injury, arthritis, muscular-skeletal conditions, neurological disease, tick and vector-borne disease, other insect-transmitted or tropical disease, and cancer. The CPMRP seeks to support and promote innovative, high-impact research to prevent the development and improve the management of chronic pain, with specific emphasis on the utilization and implementation of non-opioid therapies or non-addictive complementary methods. Applications from investigators within the military Services and applications involving multidisciplinary collaborations among academia, industry, the military Services, the U.S. Department of Veterans Affairs (VA), and other Federal Government agencies are highly encouraged.
https://cdmrp.army.mil/funding/cpmrp
Investigator-Initiated Research Award – Preproposal due September 13, 2019
Independent investigators at all academic levels (or equivalent)
· Supports research that will make an original and important contribution to the field of research or patient care in the Focus Area of Chronification of Pain.
· Multidisciplinary collaborations and innovative approaches are encouraged.
· Clinical trials are not allowed.
· Pre-application submission is required; application submission is by invitation only.
· The maximum allowable funding for the entire period of performance is $900,000 for direct costs.
· Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
· The maximum period of performance is 4 years.
Translational Research Award – Preproposal due September 13, 2019
Independent investigators at all academic levels (or equivalent)
· Supports translational research that will accelerate the movement of efficacious, evidence-based ideas into clinical applications.
· Research must address one or both of the Focus Areas of Implementation Science and Comparative Effectiveness.
· Studies to develop novel pharmacological therapies or non-pharmacological approaches that consist entirely of a clinical trial will not be funded.
· Effectiveness-implementation hybrid studies that incorporate biopsychosocial models of assessment are encouraged.
· Pre-application submission is required; application submission is by invitation only.
· The maximum allowable funding for the entire period of performance is $1,400,000 for direct costs.
· Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
· The maximum period of performance is 4 years
A pre-application is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) at https://eBRAP.org prior to the pre-application deadline. All applications must conform to the final Program Announcements and General Application Instructions available for electronic downloading from the Grants.gov website. The application package containing the required forms for each award mechanism will also be found on Grants.gov. A listing of all CDMRP and other USAMRDC extramural funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.
For email notification when Program Announcements are released, subscribe to program-specific news and updates under “Email Subscriptions” on the eBRAP homepage at https://eBRAP.org. For more information about the CPMRP or other CDMRP-administered programs, please visit the CDMRP website (https://cdmrp.army.mil).
Point of Contact:
CDMRP Help Desk
301-682-5507
help@eBrap.org
